IV Nutrition

The question every serious franchise investor asks before writing a six-figure check is not "Is this a good concept?" but rather "Is this the right brand at the right moment in a market that is structurally growing?" For the IV hydration and nutrient therapy category, the timing argument has rarely been stronger, and IV Nutrition sits at the intersection of three powerful forces: a measurably underserved consumer need for proactive wellness, a franchise model that entered the market early enough to claim territory while remaining accessible enough to attract qualified operators, and a founding team with clinical credibility that most competitors in this space cannot replicate. IV Nutrition was founded in 2017 by Dr. Tara Zeller and Dr. Jason Fechter, two clinicians whose personal and professional experience with intravenous nutrient therapy convinced them that widespread nutritional deficiencies were being chronically undertreated by the traditional healthcare system. Their first clinic opened in Kansas City, and the company is headquartered in Overland Park, Kansas. Dr. Jason Fechter serves as CEO and Co-Founder, a leadership structure that keeps clinical philosophy embedded at the executive level. The brand began offering franchise opportunities in March 2018, less than 12 months after its founding, and by October 2023 had grown to 26 clinics across 14 states, supporting 17 franchisees alongside seven corporate-owned locations. The most recent data reflects 30 active units, with 24 open franchises and 8 corporate locations, and the brand has sold over 100 territories, signaling a pipeline of expansion that has not yet been fully converted to open doors. With locations confirmed in 13 states including Arizona, Colorado, Florida, Illinois, Missouri, Texas, Tennessee, Virginia, and others, IV Nutrition has built a geographic footprint concentrated strategically in the South, which accounts for 13 franchise locations, and in anchor states like Missouri and Texas where brand recognition compounds marketing investment. For franchise investors evaluating the IV Nutrition franchise opportunity, this is a brand that has cleared the earliest and riskiest stage of franchise development and is now operating with the infrastructure of a mature system while still offering territory availability that a more saturated brand cannot.

The structural tailwinds supporting the IV hydration and nutrient therapy category are among the most durable in the entire franchise universe, rooted not in consumer fashion but in demographic inevitability and a measurable shift in how Americans conceptualize healthcare spending. The global parenteral nutrition solutions market was valued at approximately $6.83 billion in 2024 and is projected to reach between $10.35 billion and $14.7 billion by 2034 and 2035 respectively, depending on the forecast model, with compound annual growth rates ranging from 5.82% to 6.7% across major research sources. North America dominates this market, holding over 35% of global consumption and commanding a 42.26% revenue share in 2025, with the United States holding the largest individual country share within that regional block. Globally, approximately 30 million IV infusions are administered daily, and the demand side is being amplified by rising chronic disease prevalence, an expanding geriatric population, and a post-pandemic consumer mindset that has permanently elevated awareness of immune function and preventive wellness. The COVID-19 pandemic alone drove an estimated 25% rise in IV therapy usage across Asia-Pacific markets between 2021 and 2023, a behavioral shift that research consistently shows carries into long-term utilization habits. Within the U.S. specifically, the homecare IV therapy segment represents close to 10% of total market volume and is one of the fastest-growing sub-segments, with approximately 15 million patients receiving IV fluids at home annually. Consumer trends have accelerated the expansion of IV treatment menus well beyond basic rehydration into anti-aging protocols, immune-boosting formulations, NAD+ therapy, and fully customizable drip cocktails tailored to individual biomarker profiles, a personalization trend that plays directly into IV Nutrition's functional medicine operating philosophy. For franchise investors, the combination of a multi-billion-dollar addressable market, a CAGR firmly above 5% across all major forecasts, and a fragmented competitive landscape with no single dominant national brand creates the kind of category conditions where early-positioning franchisees historically capture disproportionate value.

The IV Nutrition franchise investment begins with an initial franchise fee of $49,500, a figure that positions the brand competitively within the alternative care and IV therapy sub-sector where franchise fees for comparable wellness concepts typically run higher. The total initial investment required to open an IV Nutrition franchise ranges from $198,050 to $402,550, with the spread driven primarily by leasehold improvements and buildout costs, which alone range from $20,000 to $125,000 depending on the condition of the retail space and the geographic market. Additional cost line items include a $5,000 training fee, a Store in a Box package priced between $65,000 and $75,000, initial inventory between $13,000 and $16,000, signage between $4,000 and $12,000, an initial marketing investment between $5,000 and $10,000, and three months of working capital ranging from $25,000 to $80,000. A separate investment range cited in current franchise data places the cost between $113,000 and $348,120, reflecting format and market variability. The liquid capital requirement for an ideal candidate is approximately $150,000 to $200,000. The ongoing fee structure consists of a royalty rate of 6.00% of gross sales and a brand fund contribution of 2% of gross sales, with franchisees who participate in cooperative advertising contributing up to an additional 1% of gross sales as determined by the cooperative. Critically, the IV Nutrition franchise investment range sits significantly below the sub-sector average of $294,531 to $623,123 for alternative care franchises, making this an accessible entry point relative to clinical peers with similar service offerings. The average clinic footprint is approximately 1,700 square feet, a format size that constrains buildout costs while remaining large enough to accommodate multiple treatment bays and the staffing infrastructure required for clinical operations. In October 2023, IV Nutrition formalized a partnership with FranDevCo, a specialized franchise development company, to lead its franchise growth efforts, adding professional development infrastructure that typically accelerates both lead generation and franchisee qualification quality.

Daily operations at an IV Nutrition franchise are fundamentally clinical in nature, requiring franchisees to build and manage a team of licensed healthcare professionals including nurses, paramedics, and EMTs, with a medical director overseeing all clinical protocols and compliance. This staffing model is one of the more operationally demanding aspects of the IV Nutrition franchise, and franchisees are advised explicitly to hire properly certified healthcare professionals rather than attempting to staff clinics with unlicensed personnel. Franchisees who are themselves licensed healthcare providers can directly administer services to clients, while non-clinical owner-operators function in a management and business development role, overseeing financial performance, selecting and hiring the clinic director, and participating in the brand's required monthly owner calls and annual conferences. The training program is a 14-day on-site immersion supplemented by an interactive online Learning Management System, with the full curriculum delivering 60 hours of on-the-job training and 40 hours of classroom instruction, for a total of 100 structured training hours before opening. During the critical first week of store operations, the corporate team provides direct on-site support, a feature franchisees consistently cite as reducing launch-week operational risk. Ongoing support infrastructure includes bi-monthly training classes, monthly owner calls, and unlimited cost-free supplementary training at any corporate location, a benefit with compounding value as service menus expand. IV Nutrition holds corporate medical licenses across the U.S., which reduces the regulatory burden on individual franchisees navigating state-specific healthcare licensing requirements, and the brand maintains a proprietary construction partnership designed to accelerate clinic buildout timelines. The company's project management support coordinates resources and timelines during the pre-opening phase, covering licensing, regulatory navigation, and buildout coordination simultaneously. Optimal site criteria center on high-visibility retail spaces in upper-middle-income demographic areas, preferably near complementary health services or upscale retail centers, a positioning strategy that drives qualified foot traffic from a consumer base already spending on wellness.

Item 19 financial performance data is not disclosed in the current Franchise Disclosure Document for the database-tracked version of IV Nutrition's FDD. However, the brand's own published financial representations and independent research data provide meaningful benchmarks for evaluating unit-level economics. Average unit volume for an IV Nutrition franchise is reported at $560,000, with more recent 2024 data indicating average gross revenue of $616,994 per location. That $616,994 average gross revenue figure is reported as nearly 94% higher than the sub-sector average of $317,965 for comparable alternative care franchise concepts, a margin of outperformance that, if accurate and sustained across new units, represents a material differentiator in a category where many brands struggle to reach break-even. Company-owned outlets demonstrate net profits of $392,253, though franchisee net margins will differ due to royalty and advertising fees totaling at least 8% of gross sales plus the $2,000 monthly brand fund contribution component. The franchise payback period is estimated between 3.6 and 5.6 years, a range consistent with wellness and clinical service franchises that require higher upfront staffing and buildout investment but generate recurring membership revenue once stabilized. The business model is built around a membership structure in which average member clients visit 32 times per year, compared to approximately 3.2 visits annually for non-member clients, creating a stark 10-to-1 frequency differential that makes membership conversion the single most important driver of predictable monthly revenue. Franchisees evaluating the IV Nutrition franchise cost against projected returns should model conservatively against the lower end of the revenue range while pressure-testing membership enrollment assumptions, as the spread between a clinic with strong membership penetration and one relying primarily on transactional clients is likely to be the dominant variable explaining performance differences across the system.

IV Nutrition's unit count trajectory reflects deliberate, staged expansion rather than aggressive mass-market rollout. The brand grew from 5 franchised outlets in 2020 to 23 franchised locations by 2024, representing more than 4.5 times growth in franchised units over four years. As of the most recent count, the system includes 30 active units with 24 open franchises, and the company has stated a target pace of two to six new clinic openings per month, an ambitious range that, if sustained, would approximately double the current unit count within 12 to 24 months. The brand has sold over 100 territories, meaning the signed-but-not-yet-open pipeline is substantially larger than the current operating unit base, a positive signal for system momentum but also a metric that prospective franchisees should monitor as it translates into operational data. On the service innovation front, IV Nutrition is actively expanding its treatment menu to include semaglutide injections and ozone therapy, with hormone replacement therapy also in development, positioning the brand to capture consumer spending that currently flows to medical spas and functional medicine clinics rather than dedicated IV therapy centers. The brand also emphasizes cutting-edge modalities including red light therapy, extending the per-visit revenue opportunity and differentiating the in-clinic experience from single-service competitors. In 2025, IV Nutrition received recognition from AusTrade, the Australian government's trade promotion agency, for its gut health product line, a development that signals early-stage international expansion potential for the brand's product offerings beyond the clinic environment. The clustering strategy in anchor states like Missouri, Texas, Colorado, Illinois, and Florida reflects a deliberate regional density approach designed to build brand recognition at the market level before expanding into new territories, a playbook that maximizes co-op advertising efficiency and reduces per-franchisee marketing burden in established markets.

The ideal IV Nutrition franchisee is described by the company as a motivated entrepreneur with a genuine passion for health and wellness and strong leadership capabilities, and critically, healthcare experience is explicitly not required given the depth of training and the corporate support infrastructure in place. This makes the IV Nutrition franchise opportunity accessible to business operators from outside the clinical world, provided they are prepared to hire and manage a team of licensed healthcare professionals and absorb the operational complexity that clinical service delivery entails. Multi-unit development is consistent with the brand's territory sales pace, having sold over 100 territories against a current operating base of approximately 30 units, and franchisees with management infrastructure capable of overseeing multiple locations are likely well-suited to this model. Available territories remain open across the United States, with the brand's stated geographic expansion focus directed toward new markets beyond its current 13-state presence. Optimal market profiles center on upper-middle-income suburban areas near complementary health and wellness services, a demographic that correlates with both the highest willingness-to-pay for premium IV therapy and the strongest membership conversion rates. The average clinic at approximately 1,700 square feet can typically be built out and opened within the brand's standard project management timeline, with the proprietary construction partnership designed to compress the period between lease signing and opening day. Prospective franchisees should factor into their timeline the state-specific licensing and regulatory requirements for clinical operations, a process that IV Nutrition's corporate medical licensing infrastructure is designed to support but that varies materially in complexity and duration by state.

For investors conducting serious franchise due diligence, IV Nutrition presents a compelling case study in early-category positioning within a sector that is structurally growing, demographically supported, and still competitively fragmented at the national brand level. The brand's founding by two clinicians in 2017 gave it operational credibility that marketing-first competitors lack, the partnership with FranDevCo in October 2023 added professional development infrastructure, and an average gross revenue of $616,994 against a total investment ceiling of approximately $402,550 suggests a revenue-to-investment ratio that warrants rigorous analysis. The FPI Score of 57, classified as Moderate, reflects a system that has demonstrated real growth but is still in the scale-up phase where franchisee outcomes have not yet stabilized across a large enough unit base to produce high-confidence performance benchmarks, a reality that elevates the importance of thorough due diligence including franchisee interviews, territory analysis, and market-level competitive assessment. PeerSense provides exclusive due diligence data including SBA lending history, FPI score analysis, location maps with Google ratings, FDD financial data, and side-by-side comparison tools that allow investors to benchmark the IV Nutrition franchise against every other brand in the same category using standardized, independently verified metrics. The combination of accessible entry costs relative to sub-sector averages, a membership-driven recurring revenue model, a growing treatment menu, and a 100-plus territory pipeline creates an investment thesis worth examining with the full analytical toolkit. Explore the complete IV Nutrition franchise profile on PeerSense to access the full suite of independent franchise intelligence data.